Has anyone survived asbestosis?

Surviving Asbestosis and Mesothelioma: Glimmers of Hope

Asbestosis, a chronic lung condition caused by asbestos exposure, is not cancer—but it’s serious. Over time, scar tissue builds up in the lungs, making breathing increasingly difficult. While there’s no cure, survival varies greatly depending on the individual, how early it’s caught, and the quality of care. On average, patients live between 12 to 21 months after diagnosis when treatment is involved, but some live significantly longer with proper management.

It’s important to distinguish asbestosis from mesothelioma, a rare cancer directly linked to asbestos. Pleural mesothelioma, which affects the lining of the lungs, has historically had a grim outlook. However, hope is emerging. A 2023 clinical trial showed that 23% of patients with advanced pleural mesothelioma lived more than three years when treated with a combination of immunotherapy and chemotherapy—a meaningful improvement over past outcomes.

Even more encouraging: those with peritoneal mesothelioma, which affects the abdominal lining, tend to have better survival rates. With aggressive treatment, including surgery and heated chemotherapy, some patients live several years, even beyond five in certain cases.

While both conditions are tied to asbestos and carry serious risks, medical advances are slowly changing the landscape. Early detection, specialized care, and emerging therapies like immunotherapy are extending lives and improving quality of life. Every survivor story adds not just hope, but momentum for better treatments. As research continues, what once seemed like a short timeline is, for some, becoming a longer journey—proof that survival, while not guaranteed, is possible.